About
CSL appears at No. 667 in the 2026 Global 2000, a multi-factor ranking based on sales, profits, assets and market value. The company is headquartered in Melbourne, Australia and operates primarily in drugs & biotechnology. Reported figures used for the ranking include $15.3B in sales, $1.4B in profit, $37.9B in assets and a market value of $33.6B.